| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.1 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |